Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 214 (1), 1-9
- https://doi.org/10.1016/j.canlet.2004.06.032
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor MicroenvironmentMolecular & Cellular Proteomics, 2004
- Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine ProductionMolecular Biology of the Cell, 2004
- Cell‐free DNA is released from tumor cells upon cell death: A study of tissue cultures of tumor cell linesJournal of Clinical Laboratory Analysis, 2003
- Apoptotic Release of Histones from NucleosomesJournal of Biological Chemistry, 2002
- Release of cytokeratin‐18 and ‐19 fragments (TPS and CYFRA 21‐1) into the extracellular space during apoptosisJournal of Cellular Biochemistry, 2002
- The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell linesInternational Journal of Cancer, 2001
- Detection of Apoptosis and Expression of Apoptosis-associated Proteins as Early Predictors of Prognosis after Irradiation Therapy in Stage IIIb Uterine Cervical CancerJapanese Journal of Cancer Research, 2000
- Apoptosis in breast cancer as related to histopathological characteristics and prognosisEuropean Journal Of Cancer, 1994
- CYFRA 21-1: A new marker in lung cancerCancer, 1993
- Radio-immunolocalization in Nude Mice Using Anticytokeratin Monoclonal AntibodiesTumor Biology, 1990